Chrome Extension
WeChat Mini Program
Use on ChatGLM

7152 CAHtalyst: Results from the Randomized, Double-Blind, Placebo-Controlled Period of A Phase 3 Trial of Crinecerfont, A Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, in Adults with Classic Congenital Adrenal Hyperplasia

Journal of the Endocrine Society(2024)

Cited 0|Views3
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined